✦ LIBER ✦

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

✍ Scribed by Keith C Bible; Vera J Suman; Julian R Molina; Robert C Smallridge; William J Maples; Michael E Menefee; Joseph Rubin; Kostandinos Sideras; John C Morris III; Bryan McIver; Jill K Burton; Kevin P Webster; Carolyn Bieber; Anne M Traynor; Patrick J Flynn; Boon Cher Goh; Hui Tang; Susan Percy Ivy; Charles Erlichman

Book ID: 117785457
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 279 KB
Volume: 11
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(10)70203-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Multicenter Phase 2 Trial of Pazopanib

A Multicenter Phase 2 Trial of Pazopanib in Metastatic and Progressive Medullary Thyroid Carcinoma: MC057H

✍ Bible, Keith C.; Suman, Vera J.; Molina, Julian R.; Smallridge, Robert C.; Maple 📂 Article 📅 2014 🏛 Endocrine Society 🌐 English ⚖ 344 KB

Paclitaxel in Pretreated Metastatic Peni

Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study

✍ Giuseppe Di Lorenzo; Piera Federico; Carlo Buonerba; Nicola Longo; Giacomo Carte 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 241 KB

396 Paclitaxel in Pretreated Metastatic

396 Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study

✍ Verze, P.; Di Lorenzo, G.; Imbimbo, C.; Longo, N.; Palmieri, A.; Fusco, F.; De P 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Preliminary results of phase III study o

Preliminary results of phase III study of mitomycin C versus estramustine in progressive metastatic prostate cancer refractory to hormonal therapy — results of EORTC GU group study no. 30865

✍ Newling, D.; Fossa, S.; Tunn, U.; Kurth, K.H.; Pauw, M.de; Sylvester, R. 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 130 KB

A Phase II Safety and Efficacy Study of

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

✍ Pili, Roberto; Qin, Rui; Flynn, P.J.; Picus, Joel; Millward, Michael; Ho, Wing M 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 791 KB

A phase 2 study of carboplatin plus doce

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel

✍ Robert W. Ross; Tomasz M. Beer; Susanna Jacobus; Glenn J. Bubley; Mary-Ellen Tap 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND. Prostate cancer is the second leading cause of cancer mortality among men in the U.S. To the authors' knowledge, there is no proven, effective, second‐line therapy for docetaxel‐refractory disease. Recent data suggest that platinum salts may be effective when combined wi